Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.34
0.040.43%
Pre-Market: 8:05 AM EDT
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Viatris Stock Price, Quotes and Forecasts | NASDAQ:VTRS | Benzinga
Explore Viatris stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VTRS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Viatris (VTRS) stock?
You can purchase shares of Viatris (NASDAQ:VTRS) through any online brokerage.
Who are Viatris (VTRS) competitors?
Other companies in Viatris’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
What is the forecast, or price target, for Viatris (VTRS) stock?
Viatris has a consensus price target of $11.63.
What is the current price for Viatris (VTRS)?
The stock price for Viatris (NASDAQ: VTRS) is $9.34 last updated March 25, 2025 at 8:05 AM EDT.
Does Viatris (VTRS) pay a dividend?
A quarterly cash dividend of 0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on March 18, 2025 to stockholders of record on March 10, 2025.
When is Viatris (NASDAQ:VTRS) reporting earnings?
Viatris’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Viatris (VTRS) going to split?
There is no upcoming split for Viatris.
What sector and industry does Viatris (VTRS) operate in?
Viatris is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.